Navigation Links
Boehringer Ingelheim's Jeff Huth Elected as National Pharmaceutical Council's Chairman of the Board
Date:11/8/2013

WASHINGTON, Nov. 8, 2013 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Jeff Huth, Senior Vice President, Managed Markets, Boehringer Ingelheim Pharmaceuticals Inc. (BI), has been elected chairman of its Board of Directors for 2013-14. Mr. Huth has served on NPC's Board since 2009 and has previously held the positions of vice chair and treasurer.

(Photo:  http://photos.prnewswire.com/prnh/20131108/DC13524)

"Throughout his tenure on our board, Jeff has been dedicated to promoting NPC and its role as a leading health care policy research organization," said NPC President Dan Leonard. "We're looking forward to having Jeff play an even more active role in leading NPC's efforts on issues related to balancing the needs of patients with the population, the value of pharmaceuticals, and the use of real-world evidence."

Mr. Huth has more than 30 years of experience in the pharmaceutical industry, where he has served in a wide spectrum of roles ranging from pre-clinical development to marketing and sales management.  His career with Boehringer Ingelheim has included international assignments at BI's affiliate in the United Kingdom and at corporate headquarters in Germany. Upon returning to the U.S., he assumed responsibility for marketing and in 2009 moved to his current position, for which he is responsible for pricing and contracting, trade relations, health economics and leading field-based teams interacting with customers in the private and government payer channels. In the U.S., BI develops and markets therapies in the respiratory, cardiovascular, metabolic, anti-viral and oncology areas.

The NPC Board also elected Anne Whitaker, President, North America Pharmaceuticals, Sanofi, as Vice Chair; David Martin, Vice President, Managed Markets, Value & Access Group, Eisai Inc. as Treasurer; and Giovanni Caforio, MD, President, U.S. Pharmaceuticals, Bristol-Myers Squibb Company, and Steven Romano, MD, Senior Vice President, Head, Medicines Development Group, Pfizer Inc, to serve on the executive committee.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow. 


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheims interferon-free hepatitis C treatment portfolio strengthened by promising interim Phase 2a data
2. Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
3. Boehringer Ingelheim Pharmaceuticals, Inc. colabora con Univision Communications Inc. para lanzar una campaña integrada en español
4. Boehringer Ingelheim Pharmaceuticals, Inc. Collaborates With Univision Communications Inc. To Launch An Integrated Campaign In Spanish
5. Boehringer Ingelheims investigational volasertib receives FDA Breakthrough Therapy designation
6. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
7. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
8. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
9. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
10. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
11. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has ... 2016 Top Workplaces National Standard. To learn ... ... (PRNewsFoto/Diplomat Pharmacy, Inc.) ... an employee survey administered by WorkplaceDynamics, LLC, a research firm specializing ...
(Date:12/8/2016)... 8 de dezembro de 2016  A Mederi Therapeutics Inc . anunciou ... tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto ... ... Live Stretta procedure performed and broadcast during the ... Wuhan Union Hospital ...
(Date:12/8/2016)... DANVILLE, Pa. , Dec. 8, 2016  A ... physicians reports that the use of opioid therapy to ... actually increase the likelihood of more harmful consequences, including ... Davis , M.D., and Zankhana Mehta , M.D., ... current research on chronic opioid therapy. The study was ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... The Dan Carlisle Agency, an ... County, is announcing the launch of a charity drive to raise support and ... women and children in Birmingham has grown steadily since the 1980’s, and the ...
(Date:12/8/2016)... Louis, MS (PRWEB) , ... December 08, 2016 , ... ... that serve commercial and residential clients in and around the Hancock County area, is ... for the Hancock County Food Pantry. , The Hancock County Food Pantry has worked ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication to ... of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of ... both sides of the Atlantic with a mechanism to comply with EU data protection ...
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader in sealed healthcare lighting ... MPCNGX is a multi-function, sealed, LED luminaire that meets the needs of everyone in ... it’s needed. , A 2’ x 4’ model features four modes: reading, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Smart Device Remote Control through a new partnership with Splashtop Inc. This remote ... its mobile solutions to help businesses maximize their uptime and productivity. , Wavelink ...
Breaking Medicine News(10 mins):